Scalper1 News
Generic-drug maker Par Pharmaceutical Holdings has filed to go public, less than three years after it was taken private in a buyout. In its prospectus filed Friday, the company, which plans to trade as PRX, described what it’s been up to since private-equity firm TPG acquired it in September 2012. These include filing 61 generic-drug applications, acquiring Indian clinical research organization Ethics Bio Lab and expanding its manufacturing Scalper1 News
Scalper1 News